New Study Shows Copan’s Colibrí™ Automates MALDI-TOF Sample Preparation with High Accuracy
A new study published in Diagnostic Microbiology & Infectious Disease shows that Copan’s Colibrí™ instrument accurately automates sample preparation…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 May 24
A new study published in Diagnostic Microbiology & Infectious Disease shows that Copan’s Colibrí™ instrument accurately automates sample preparation…
02 May 24
Immunomodulator II patent grant further strengthens robust intellectual property portfolio for partnering
02 May 24
Under the collaboration, the companies are developing antisense oligonucleotides (ASOs) for multiple neurodegenerative diseases
01 May 24
Bayer and Evotec are expanding their collaboration to develop innovative therapies in precision cardiology, and the strategic alliance…
01 May 24
The positive top-line results revealed that the Phase 2/3 trial achieved its primary endpoint of improvement on the…
01 May 24
Lupkynis’ updated label no longer includes the disclaimer regarding its safety and efficacy beyond one year and incorporates…
01 May 24
The partnership, spread across various therapeutic fields, aims to assess the use of polygenic risk scores in improving…
01 May 24
Primary endpoint and key secondary endpoint of study met; drug was well tolerated, with no safety concerns identified
01 May 24
Proceeds to advance the first covalent biologic platform and pipeline to the clinic of novel protein drugs that…
30 Apr 24
ONO will merge Deciphera with and into its fully owned subsidiary, with Deciphera as the surviving entity, which…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates